MOTS-C nasal spray represents one of the most intriguing frontiers in mitochondrial peptide research. MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino acid peptide encoded within mitochondrial DNA — a discovery that fundamentally challenged the long-held assumption that mitochondria produce no biologically active peptide hormones. Since its identification in 2015, research has accelerated rapidly, with investigators exploring how intranasal delivery models might offer a practical route for laboratory studies of this metabolically active compound.
Interest in MOTS-C nasal spray formulations has grown alongside broader scientific curiosity about mitochondrial-derived peptides (MDPs) and their roles in cellular energy regulation, metabolic signaling, and stress response pathways. Studies have investigated whether intranasal administration may allow MOTS-C to bypass first-pass metabolism while providing efficient systemic distribution — making it a compelling subject for researchers focused on non-invasive peptide delivery methods.
Research-only notice: This content is provided for educational discussion and laboratory research purposes only. No medical claims are made or implied. MOTS-C is not approved for human therapeutic use and is intended strictly for in vitro and preclinical research settings.
MOTS-C - 40MG — Research-Grade Reference Material MOTS-C - 40MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Selank - 10MG
$45.00$33.75 with 1st order
SLU-PP-332 - 5MG
$75.00$56.25 with 1st order
Cardiogen - 20MG
$50.00$37.50 with 1st order
Frequently Asked Questions
What is MOTS-C and where does it come from?
MOTS-C is a 16-amino acid mitochondrial-derived peptide encoded within the 12S ribosomal RNA gene of the mitochondrial genome. It was first characterized by researchers in 2015 and is notable for being one of the few known peptides originating from mitochondrial DNA rather than nuclear DNA. Studies have explored its roles in metabolic regulation and cellular stress response.
What has research shown about MOTS-C’s mechanism of action?
Preclinical research suggests MOTS-C may activate AMPK (AMP-activated protein kinase) pathways, influence the folate cycle and de novo purine synthesis, and translocate to the cell nucleus under stress conditions to modulate gene expression. Studies have also examined its interactions with mitochondrial function and reactive oxygen species (ROS) signaling.
Why do researchers study MOTS-C in a nasal spray format?
Intranasal delivery is studied as a potential route for peptides that may be rapidly degraded when administered via other methods. Researchers have investigated nasal spray formats because the olfactory and nasal mucosa pathways may offer direct systemic absorption and, in some models, potential access to the central nervous system — though these delivery dynamics are still under active investigation in preclinical settings.
Has MOTS-C been studied in relation to aging or longevity research?
Yes. Research has explored MOTS-C in the context of mitochondrial aging biology. Studies in animal models have observed that MOTS-C levels appear to decline with age, and some investigations have examined whether exogenous administration in preclinical models influences age-related metabolic markers. These findings remain preliminary and have not been validated in human clinical trials.
What is the difference between MOTS-C and other mitochondrial-derived peptides like humanin?
Both MOTS-C and humanin are mitochondrial-derived peptides, but they differ in sequence, size, and proposed signaling roles. Humanin is a 21-amino acid peptide primarily studied in the context of neuroprotection and cell survival, while MOTS-C research has focused more heavily on metabolic regulation and AMPK pathway activation. Both are subjects of active preclinical investigation.
Is MOTS-C nasal spray legal for research purposes?
MOTS-C is available as a research compound for licensed laboratory use. It is not approved by the FDA as a drug or therapeutic agent and must not be used in humans outside of formally authorized clinical research settings. Researchers should consult applicable regulations in their jurisdiction before acquiring or working with this compound.
What models have been used to study MOTS-C?
Preclinical research has employed mouse models, cell culture systems, and in vitro assays to investigate MOTS-C signaling. Murine studies have examined metabolic outcomes including glucose regulation and insulin sensitivity markers. In vitro studies have explored mechanisms involving AMPK, the folate-AICAR pathway, and nuclear translocation under oxidative stress conditions.
The Science Behind MOTS-C: A Mitochondrial Peptide With Nuclear Reach
MOTS-C is encoded within the mitochondrial genome — specifically within the 12S rRNA gene — making it one of the rare examples of a biologically active peptide arising from what was once considered purely structural non-coding RNA. The peptide consists of 16 amino acids with the sequence MRWQEMGYIFYPRKLR and is conserved across mammalian species, suggesting functional significance preserved through evolution.
MOTS-C - 40MG — Research-Grade Reference Material MOTS-C - 40MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Selank - 10MG
$45.00$33.75 with 1st order
SLU-PP-332 - 5MG
$75.00$56.25 with 1st order
Cardiogen - 20MG
$50.00$37.50 with 1st order
What makes MOTS-C particularly compelling in research contexts is its apparent dual compartment behavior. Under basal conditions, it operates primarily within the mitochondrial matrix. However, studies have demonstrated that under conditions of cellular stress — including oxidative stress and nutrient deprivation — MOTS-C can translocate to the cell nucleus, where it has been shown to interact with nuclear gene regulatory elements. This mitochondria-to-nucleus communication pathway, sometimes referred to as retrograde signaling, is a subject of intense interest in cell biology and aging research.
AMPK Activation and the Folate-AICAR Pathway
One of the most studied mechanisms attributed to MOTS-C in preclinical models involves activation of AMPK (adenosine monophosphate-activated protein kinase), a master metabolic sensor often described as a cellular energy gauge. Research has suggested that MOTS-C may influence the folate cycle, disrupting one-carbon metabolism in a manner that leads to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) — a naturally occurring AMPK activator. This indirect AMPK activation pathway distinguishes MOTS-C from direct pharmacological AMPK agonists and has drawn attention from researchers studying mitochondrial-nuclear crosstalk in metabolic regulation.
For researchers already familiar with MOTS-C’s core metabolic mechanisms, the nasal spray delivery format raises additional questions about whether bioavailability profiles differ meaningfully from injectable administration in preclinical models.
Intranasal Delivery of Peptides: Research Rationale
Intranasal peptide delivery has become a significant area of pharmaceutical and research interest precisely because many peptide compounds face bioavailability challenges through oral routes — enzymatic degradation in the gastrointestinal tract and liver first-pass metabolism can substantially reduce systemic exposure. The nasal mucosa, with its highly vascularized epithelium and relatively large surface area, has been studied as an alternative absorption route for a range of bioactive peptides.
Researchers studying intranasal peptide delivery are particularly interested in two distinct pathways: systemic absorption via nasal vasculature, and direct nose-to-brain transport via olfactory and trigeminal nerve pathways. The latter route has been explored extensively in the context of neuropeptide research. As noted in the NAD+ 500MG Nasal Spray research guide, intranasal delivery has been applied to a diverse range of research compounds — including metabolic and mitochondrial-targeting molecules — with the goal of studying distribution kinetics in preclinical models.
Peptide Stability Considerations in Nasal Formulations
For researchers working with MOTS-C nasal spray, formulation stability is a key consideration. Peptides are susceptible to proteolytic degradation, temperature fluctuations, and pH changes that can affect structural integrity and activity. Laboratory protocols for intranasal peptide research typically involve careful attention to storage conditions, buffer composition, and the use of stabilizing excipients. These variables must be controlled to ensure consistent results across experimental runs.
MOTS-C – 10MG Nasal Spray for research →
What Preclinical Studies Have Investigated
Metabolic Regulation Research
Among the most replicated findings in MOTS-C preclinical research is its apparent influence on glucose metabolism and insulin sensitivity markers in murine models. Studies have observed that MOTS-C administration in diet-induced obese mice was associated with improved metabolic parameters, including reductions in fasting glucose levels and body weight — effects attributed in part to skeletal muscle AMPK activation. Researchers have noted that these findings bear similarities to the physiological effects of exercise-induced AMPK activation, positioning MOTS-C within a broader class of compounds being studied as metabolic regulators.
This metabolic signaling angle draws natural comparisons with other research compounds in the exercise-mimetic and mitochondrial activation space. For example, SLU-PP-322 research has explored ERR agonism as a parallel pathway for influencing mitochondrial biogenesis and metabolic efficiency in preclinical models — representing a complementary area of investigation for researchers building multi-pathway metabolic research programs.
Aging Biology and Mitochondrial Decline
Research has examined the relationship between MOTS-C levels and biological aging. Studies using aging animal models have reported an age-dependent decline in circulating MOTS-C concentrations, and some investigations have observed that supplementation in older animals was associated with improved physical performance metrics and metabolic biomarkers. These findings have positioned MOTS-C as a potential subject of interest in longevity biology research, though investigators consistently note that mechanistic translation to longer-lived species — including humans — requires substantially more investigation.
Researchers interested in the intersection of mitochondrial health and longevity-oriented peptide research may find it valuable to examine MOTS-C alongside other mitochondrial-targeting research compounds. The 2026 peptide research landscape article provides a broader overview of compounds attracting renewed scientific attention in the longevity and metabolic research space.
Stress Response and Nuclear Translocation Studies
A distinctive line of research has focused on MOTS-C’s behavior under conditions of cellular stress. In vitro studies have demonstrated that oxidative stress and metabolic stress can trigger nuclear translocation of MOTS-C, where it appears to act as a transcriptional co-regulator influencing antioxidant response elements. Some investigations have examined whether this nuclear activity contributes to cellular resilience and adaptive stress responses — a mechanism that would distinguish MOTS-C from purely metabolic peptides and expand its research relevance into the domain of stress biology.
MOTS-C in the Context of Broader Mitochondrial Peptide Research
MOTS-C belongs to a family of mitochondrial-derived peptides (MDPs) that also includes humanin, SHLP1-6 (small humanin-like peptides), and DALE. Collectively, these peptides represent a new frontier in endocrinology — the mitochondrial endocrine system — and their study has prompted a fundamental reconsideration of mitochondria as passive energy-generating organelles. Instead, current research increasingly frames mitochondria as active signaling hubs that communicate with distant tissues via secreted peptides.
Understanding MOTS-C within this broader framework helps researchers contextualize their findings. Just as Thymosin Alpha-1 research has revealed peptides with both local and systemic regulatory roles, MOTS-C studies suggest that mitochondrially encoded peptides may participate in organism-wide signaling networks rather than acting only locally within individual cells.
Explore MOTS-C 10MG Nasal Spray for laboratory use →
Research Protocols and Laboratory Considerations
Storage and Handling
For laboratory researchers working with MOTS-C nasal spray, proper handling is essential to maintain peptide integrity. Research-grade MOTS-C should be stored according to manufacturer specifications — typically at −20°C for long-term storage. Repeated freeze-thaw cycles should be minimized to prevent peptide degradation. Researchers should work under sterile conditions and document all handling procedures as part of standard laboratory protocol.
Typical Research Concentration Ranges in Preclinical Models
Published preclinical studies have employed a range of MOTS-C concentrations in animal models. Researchers should consult current peer-reviewed literature to identify concentration ranges used in analogous studies and design experiments with appropriate controls. Dosing variables in intranasal delivery models include volume per administration, frequency, and formulation pH — all of which may influence absorption kinetics and observed biological effects.
Complementary Research Compounds
Some research programs investigating mitochondrial function and metabolic regulation have examined MOTS-C alongside other compounds with overlapping research interests. Compounds like 5-Amino-1MQ, which targets the NNMT metabolic pathway, may be studied in parallel to investigate complementary mechanisms in metabolic research models. Researchers designing multi-compound studies should carefully consider experimental design to isolate individual compound effects.
5-Amino-1MQ 50MG for metabolic pathway research →
Where These Fit in Your Research Library
Researchers building a mitochondrial and metabolic research library may find the following compounds relevant to their work:
- MOTS-C – 10MG Nasal Spray — Mitochondrial-derived peptide for metabolic and stress signaling research
- SLU-PP-322 – 5MG — ERR agonist studied as an exercise mimetic and mitochondrial biogenesis modulator
- 5-Amino-1MQ – 50MG — NNMT inhibitor investigated in metabolic and fat regulation research models
Explore the full SourcePeptides research catalog for a complete selection of research-grade peptides and compounds.
Final Takeaway
MOTS-C nasal spray research sits at the intersection of mitochondrial biology, metabolic science, and peptide delivery innovation. As one of a small number of peptides encoded directly within the mitochondrial genome, MOTS-C has prompted researchers to reconsider the endocrine capabilities of mitochondria — and preclinical studies have produced findings relevant to AMPK activation, glucose metabolism, aging biology, and cellular stress response signaling.
The intranasal delivery format introduces additional research variables worth investigating: absorption kinetics, stability profiles, and the potential for olfactory-pathway distribution all represent meaningful areas for laboratory exploration. For researchers building programs around mitochondrial signaling, metabolic regulation, or novel peptide delivery methods, MOTS-C nasal spray represents a scientifically compelling research subject supported by a growing body of peer-reviewed preclinical literature.
All research involving MOTS-C should be conducted within properly licensed laboratory settings, adhering to institutional guidelines and applicable regulatory frameworks. This compound is strictly for research purposes and is not intended for human therapeutic use.
Sources & Further Reading
- Lee C et al. — “The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance” — Cell Metabolism (2015)
- Reynolds JC et al. — “MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis” — Nature Communications (2021)
- Kim SJ et al. — “Mitochondria-derived peptides as novel regulators of metabolism” — Journal of Physiology (2018)
- Zhai D et al. — “MOTS-c peptide increases survival and decreases bacterial load in mice infected with SARS-CoV-2” — Pharmacological Research (2022)
- PubMed Search — MOTS-c intranasal peptide delivery research literature
